Evommune Ownership | Who Owns Evommune?
Evommune Ownership Summary
Evommune is owned by 109.00% institutional investors, 7.98% insiders. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 15.64% of EVMN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.36% of its assets in Evommune shares.
EVMN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evommune | 109.00% | 7.98% | -16.98% |
| Sector | Healthcare Stocks | 35.78% | 11.87% | 52.36% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Eqt fund management s.a r.l. | 4.93M | 15.64% | $113.33M |
| Ra capital management | 3.49M | 11.09% | $80.34M |
| Pivotal bioventure partners investment advisor | 1.93M | 6.11% | $44.30M |
| Andera partners | 1.90M | 6.02% | $43.62M |
| Rtw investments, lp | 1.50M | 4.77% | $34.54M |
| Jpmorgan chase | 1.46M | 4.63% | $32.11M |
| Bioimpact capital | 1.46M | 4.62% | $33.47M |
| Nan fung group | 1.44M | 4.57% | $33.13M |
| Eventide asset management | 1.21M | 3.84% | $27.80M |
| Price t rowe associates inc /md/ | 1.12M | 3.55% | $25.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nan fung group | 1.44M | 27.32% | $33.13M |
| Andera partners | 1.90M | 24.66% | $43.62M |
| Pivotal bioventure partners investment advisor | 1.93M | 15.83% | $44.30M |
| Sectoral asset management | 589.00K | 11.22% | $13.54M |
| Eqt fund management s.a r.l. | 4.93M | 11.10% | $113.33M |
| Velan capital investment management lp | 446.25K | 6.43% | $10.26M |
| Bioimpact capital | 1.46M | 2.58% | $33.47M |
| Monashee investment management | 179.34K | 2.24% | $4.12M |
| Great point partners | 325.00K | 1.72% | $7.47M |
| Kynam capital management, lp | 625.50K | 0.89% | $14.38M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | 1.46M | 2.58% | 1.34M |
| Janus henderson group | 896.70K | 0.01% | 896.70K |
| Baker bros. advisors lp | 847.39K | 0.11% | 847.39K |
| Alyeska investment group | 726.36K | 0.05% | 726.36K |
| Blackrock funding, inc. /de | 673.57K | 0.00% | 531.13K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Abrdn | - | - | -525.38K |
| Octagon capital advisors lp | 143.47K | 0.36% | -356.53K |
| Sofinnova investments | - | - | -153.32K |
| Marshall wace, llp | 879.73K | 0.02% | -108.47K |
| Sphera funds management | 78.23K | 0.29% | -87.91K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Janus henderson group | 896.70K | 0.01% | 896.70K | $20.62M |
| Baker bros. advisors lp | 847.39K | 0.11% | 847.39K | $19.48M |
| Alyeska investment group | 726.36K | 0.05% | 726.36K | $16.70M |
| Perceptive advisors | 448.35K | 0.20% | 448.35K | $10.31M |
| Freestone grove partners lp | 337.29K | 0.05% | 337.29K | $7.75M |
Sold Out
| Holder | Change |
|---|---|
| Royal bank of canada | -585.00 |
| Oxford asset management llp | -19.57K |
| Two sigma investments, lp | -21.32K |
| Qube research | -24.06K |
| Tudor investment corp et al | -31.95K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 81 | 37.29% | 34,361,905 | 26.33% | 109 | 1.46% | 61 | 3.39% | 11 | - |
| Dec 31, 2025 | 59 | - | 27,200,904 | - | 86 | - | 59 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 1.21M | 3.36% | 247.60K |
| JPMorgan Small Cap Growth A | 601.14K | 1.67% | -14.38K |
| T. Rowe Price New Horizons | 514.72K | 1.43% | -163.00 |
| American Century U.S. Small Cap Growth | 377.26K | 1.05% | 47.01K |
| American Century Small Cap Growth Inv | 377.26K | 1.05% | 47.01K |
| JPM Global Healthcare C acc USD | 371.93K | 1.03% | 113.75K |
| US Small-Cap Growth II Equity Comp | 362.73K | 1.01% | 70.48K |
| Federated Hermes Kaufmann Small Cap Grow | 325.00K | 0.90% | - |
| Federated Hermes Kaufmann Small Cap A | 325.00K | 0.90% | - |
| Vanguard Total Stock Mkt Idx Inv | 318.90K | 0.89% | - |
EVMN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools